These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 38719319)

  • 41. Evaluation of the relationship between glycated hemoglobin A1c and mean glucose levels derived from the professional continuous flash glucose monitoring system.
    Yamada M; Okada S; Oda H; Nakajima Y; C Bastie C; Kasai Y; Osaki A; Shimoda Y; Shibusawa R; Uehara R; Saito T; Ozawa A; Yamada E
    Endocr J; 2020 May; 67(5):531-536. PubMed ID: 32023560
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The effectiveness of continuous subcutaneous insulin pumps with continuous glucose monitoring in outpatient adolescents with type 1 diabetes: A systematic review.
    Matsuda E; Brennan P
    JBI Libr Syst Rev; 2012; 10(42 Suppl):1-10. PubMed ID: 27820140
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effect of initiating use of an insulin pump in adults with type 1 diabetes using multiple daily insulin injections and continuous glucose monitoring (DIAMOND): a multicentre, randomised controlled trial.
    Beck RW; Riddlesworth TD; Ruedy KJ; Kollman C; Ahmann AJ; Bergenstal RM; Bhargava A; Bode BW; Haller S; Kruger DF; McGill JB; Polonsky W; Price D; Toschi E;
    Lancet Diabetes Endocrinol; 2017 Sep; 5(9):700-708. PubMed ID: 28711468
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effectiveness of a culturally tailored diabetes education curriculum with real-time continuous glucose monitoring in a Latinx population with type 2 diabetes: the CUT-DM with CGM for Latinx randomised controlled trial study protocol.
    Ehrhardt N; Cedeno B; Montour L; Sinclair K; Ferguson G; Berberian P; Comstock B; Wright L
    BMJ Open; 2023 Dec; 13(12):e082005. PubMed ID: 38154895
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Closed-loop insulin delivery in suboptimally controlled type 1 diabetes: a multicentre, 12-week randomised trial.
    Tauschmann M; Thabit H; Bally L; Allen JM; Hartnell S; Wilinska ME; Ruan Y; Sibayan J; Kollman C; Cheng P; Beck RW; Acerini CL; Evans ML; Dunger DB; Elleri D; Campbell F; Bergenstal RM; Criego A; Shah VN; Leelarathna L; Hovorka R;
    Lancet; 2018 Oct; 392(10155):1321-1329. PubMed ID: 30292578
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Randomised controlled trial of Advanced Hybrid Closed Loop in an Adult Population with Type 1 Diabetes (ADAPT): study protocol and rationale.
    de Portu S; Vorrink L; Re R; Shin J; Castaneda J; Habteab A; Cohen O
    BMJ Open; 2022 Feb; 12(2):e050635. PubMed ID: 35110310
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Implementation of blood glucose self-monitoring among insulin-dependent patients with type 2 diabetes in three rural districts in Rwanda: 6 months open randomised controlled trial.
    Ng'ang'a L; Ngoga G; Dusabeyezu S; Hedt-Gauthier BL; Ngamije P; Habiyaremye M; Harerimana E; Ndayisaba G; Rusangwa C; Niyonsenga SP; Bavuma CM; Bukhman G; Adler AJ; Kateera F; Park PH
    BMJ Open; 2020 Jul; 10(7):e036202. PubMed ID: 32718924
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Adding a Brief Continuous Glucose Monitoring Intervention to the National Diabetes Prevention Program: A Multimethod Feasibility Study.
    Richardson KM; Schembre SM; da Silva V; Blew RM; Behrens N; Roe DJ; Marvasti FF; Hingle M
    J Diabetes Res; 2024; 2024():7687694. PubMed ID: 38919262
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Continuous glucose monitoring pilot in low-income type 1 diabetes patients.
    Sequeira PA; Montoya L; Ruelas V; Xing D; Chen V; Beck R; Peters AL
    Diabetes Technol Ther; 2013 Oct; 15(10):855-8. PubMed ID: 23865840
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Monthly Video-Consultation for Children With Type 1 Diabetes Using a Continuous Glucose Monitoring System: Design of ViDiKi, a Multimethod Intervention Study to Evaluate the Benefit of Telemedicine.
    Frielitz FS; Müller-Godeffroy E; Hübner J; Eisemann N; Dördelmann J; Menrath I; Katalinic A; Hiort O; von Sengbusch S
    J Diabetes Sci Technol; 2020 Jan; 14(1):105-111. PubMed ID: 31315446
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A Pilot Trial of Continuous Glucose Monitoring Upon Emergency Department Discharge Among People With Diabetes Mellitus.
    O'Connor MJ; Ding X; Hernandez C; Hubacz L; Church RJ; O'Connor L
    Endocr Pract; 2024 Feb; 30(2):122-127. PubMed ID: 37952581
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Evaluation of Hemoglobin A1c before and after initiation of continuous glucose monitoring in children with type 1 diabetes mellitus.
    Gurnurkar S; Owens L; Chalise S; Vyas N
    J Pediatr Endocrinol Metab; 2021 Mar; 34(3):311-317. PubMed ID: 33618445
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Association between recent exposure to continuous glucose monitoring-recorded hypoglycaemia and counterregulatory and symptom responses to subsequent controlled hypoglycaemia in people with type 1 diabetes.
    Svensson CH; Fabricius TW; Verhulst CEM; Kristensen PL; Tack CJ; Heller SR; Amiel SA; McCrimmon RJ; Evans M; Holst JJ; de Galan BE; Pedersen-Bjergaard U;
    Diabetes Obes Metab; 2024 Aug; 26(8):3213-3222. PubMed ID: 38774963
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Evaluation of a community-based pharmacy resident-led continuous glucose monitoring program within a family medicine clinic.
    Miller L; Woodyear J; Marciniak MW; Rhodes LA
    J Am Pharm Assoc (2003); 2024; 64(3):102078. PubMed ID: 38556247
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Evaluation of an algorithm to guide patients with type 1 diabetes treated with continuous subcutaneous insulin infusion on how to respond to real-time continuous glucose levels: a randomized controlled trial.
    Jenkins AJ; Krishnamurthy B; Best JD; Cameron FJ; Colman PG; Farish S; Hamblin PS; O'Connell MA; Rodda C; Rowley K; Teede H; O'Neal DN
    Diabetes Care; 2010 Jun; 33(6):1242-8. PubMed ID: 20215457
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Living with type 1 diabetes in Neno, Malawi: a qualitative study of self-management and experiences in care.
    Drown L; Adler AJ; Schwartz LN; Sichali J; Valeta F; Boudreaux C; Trujillo C; Ruderman T; Bukhman G
    BMC Health Serv Res; 2023 Jun; 23(1):595. PubMed ID: 37291520
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The Associations of Mean Glucose and Time in Range from Continuous Glucose Monitoring with HbA1c in Adults with Type 2 Diabetes.
    Selvin E; Wang D; Rooney MR; Echouffo-Tcheugui J; Fang M; Zeger S; Sartini J; Tang O; Coresh J; Aurora RN; Punjabi NM
    Diabetes Technol Ther; 2023 Jan; 25(1):86-90. PubMed ID: 36108310
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Intermittently scanned continuous glucose monitoring provides no benefit over structured self-monitoring of blood glucose in type 2 diabetes not on prandial insulin, in the context of diabetes self-management education: GLucose monitoring programme SingaporE (GLiMPSE).
    Rama Chandran S; Rahman N; Gandhi M; Tan NC; Phoon IKY; Seah DEJ; Cheah MH; Sek K; Gardner DS
    Diabetes Res Clin Pract; 2024 May; 211():111678. PubMed ID: 38642860
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Real-world outcomes of continuous glucose monitoring in adults with diabetes mellitus attending an Irish tertiary hospital.
    Courtney A; Smith D; Forde H
    Ir J Med Sci; 2023 Dec; 192(6):2763-2768. PubMed ID: 36940009
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.